PRESS RELEASE published on 04/30/2024 at 20:30, 2 years 1 month ago Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024. Spexis AG receives approval to extend deadline for publishing 2023 annual report and audited financials until May 31, 2024, due to ongoing legal discussions and negotiations with creditors Extension 2023 Annual Report Spexis AG Deadline Audited Financials
BRIEF published on 04/17/2024 at 07:20, 2 years 2 months ago Spexis AG annonce des développements importants, notamment un moratoire prolongé et des modifications stratégiques en matière de licences Spexis SA Prolongation Du Moratoire OMPTA Vente De Programmes Précliniques Licence Lonodelestat
BRIEF published on 04/17/2024 at 07:20, 2 years 2 months ago Spexis AG Announces Significant Developments Including Extended Moratorium and Strategic Licensing Changes Spexis AG Moratorium Extension OMPTAs Preclinical Program Sale Lonodelestat Licensing
PRESS RELEASE published on 04/17/2024 at 07:15, 2 years 2 months ago Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera Spexis AG extends moratorium and receives payment for antibiotics program sale while reverting lonodelestat license from Santhera Spexis AG Moratorium Extension Antibiotics Program Sale Lonodelestat License Santhera
PRESS RELEASE published on 02/08/2024 at 07:15, 2 years 4 months ago Spexis announces closing of sale of preclinical antibiotics program to Basilea Spexis AG announces the closing of the sale of a preclinical antibiotics program to Basilea, which will pay up to CHF 2 million for the program. The program targets Gram-negative bacteria, including multidrug-resistant strains. The sale is part of Spexis' strategy to divest non-core programs and assets to focus on rare diseases and oncology Spexis AG Basilea Preclinical Antibiotics Program Gram-negative Bacteria Multidrug-resistant Strains
PRESS RELEASE published on 11/08/2023 at 07:15, 2 years 7 months ago Spexis to file an application for a debt-restructuring moratorium
PRESS RELEASE published on 11/01/2023 at 07:20, 2 years 7 months ago Spexis Announces Changes to the Executive Committee
PRESS RELEASE published on 10/06/2023 at 07:30, 2 years 8 months ago Spexis to host business update conference call on October 9, 2023
PRESS RELEASE published on 09/29/2023 at 07:25, 2 years 8 months ago Spexis provides business update and announces financial results for the first half of 2023
PRESS RELEASE published on 09/28/2023 at 07:30, 2 years 8 months ago Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology
Published on 06/22/2026 at 23:25, 2 hours 20 minutes ago Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/22/2026 at 23:05, 2 hours 40 minutes ago Gamma Resources Settles Remaining Balance of Outstanding Debt
Published on 06/22/2026 at 21:05, 4 hours 40 minutes ago RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 6 hours ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/22/2026 at 15:58, 9 hours 47 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 21:07, 4 hours 37 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 4 hours 54 minutes ago Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 5 hours 12 minutes ago EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 19:27, 6 hours 18 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/22/2026 at 18:00, 7 hours 45 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION